Mr Wayne Scott Ryerson, MA, CCC-SLP | |
130 Gregory Ave, West Orange, NJ 07052-4619 | |
(973) 980-1605 | |
(973) 325-0026 |
Full Name | Mr Wayne Scott Ryerson |
---|---|
Gender | Male |
Speciality | Speech-language Pathologist |
Location | 130 Gregory Ave, West Orange, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265796056 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 41YS00069900 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Wayne Scott Ryerson, MA, CCC-SLP 130 Gregory Ave, West Orange, NJ 07052-4619 Ph: (973) 980-1605 | Mr Wayne Scott Ryerson, MA, CCC-SLP 130 Gregory Ave, West Orange, NJ 07052-4619 Ph: (973) 980-1605 |
News Archive
According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors.
Data presented today at the 2015 European Cancer Congress (ECC) demonstrates that the investigational immunotherapy atezolizumab may prevent progression of metastatic urothelial bladder cancer (mUBC) in all age groups by 2.1 months.
Researchers at the Faculty of Pharmacy at the University of Helsinki are co-ordinating an extensive project which aims to find biological activity from among organisms in the sea which would be suitable for use as a basis for pharmaceutical products. Interesting compounds isolated from organisms in the sea are chemically modified to be more suitable for medical purposes.
Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.
The New York Times: A civil trial against the drugmaker Merck is now underway in Manhattan. A retired investigator for the U.S. army is one of 1,400 people suing the company on the premise that Fosamax, a Merck drug used by millions of women with thinning bones, caused them to develop jawbone ailments.
› Verified 1 days ago
Lynn R Reed, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1199 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-414-4729 | |
Lynn N. Philippe, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1155 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-731-5100 | |
Miss Giana Nicole Resta, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 Prospect Ave, West Orange, NJ 07052 Phone: 973-325-0805 | |
Mr. Steven C Labarbera, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1199 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-243-6956 | |
Diane Rose Dearie, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Executive Dr Ste 10, West Orange, NJ 07052 Phone: 973-896-0422 | |
Velvetspeech Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 Main St Ste 340, West Orange, NJ 07052 Phone: 845-480-1261 | |
Leah Melamed Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 39 Moore Ter, West Orange, NJ 07052 Phone: 973-220-9225 |